Perrigo Company plc (NYSE:PRGO – Get Free Report) saw a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 3,790,000 shares, a decline of 17.1% from the February 28th total of 4,570,000 shares. Based on an average daily trading volume, of 1,620,000 shares, the short-interest ratio is currently 2.3 days. Approximately 2.8% of the shares of the company are short sold.
Perrigo Price Performance
PRGO traded up $0.21 during midday trading on Wednesday, reaching $27.91. 840,290 shares of the company’s stock were exchanged, compared to its average volume of 1,498,132. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The business has a 50-day simple moving average of $26.34 and a two-hundred day simple moving average of $26.17. The firm has a market capitalization of $3.81 billion, a price-to-earnings ratio of -23.85 and a beta of 0.48. Perrigo has a one year low of $23.14 and a one year high of $33.46.
Perrigo (NYSE:PRGO – Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $0.93 EPS for the quarter, topping the consensus estimate of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.20 billion. As a group, research analysts predict that Perrigo will post 2.56 EPS for the current year.
Perrigo Increases Dividend
Wall Street Analyst Weigh In
Several research firms have commented on PRGO. Argus cut Perrigo from a “buy” rating to a “hold” rating in a report on Tuesday, January 14th. StockNews.com cut Perrigo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 19th. Finally, Piper Sandler cut Perrigo from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $34.00 to $27.00 in a research report on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $33.00.
Get Our Latest Research Report on Perrigo
Insiders Place Their Bets
In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the firm’s stock in a transaction on Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the sale, the executive vice president now directly owns 33,666 shares in the company, valued at $923,795.04. This trade represents a 18.81 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.70% of the company’s stock.
Institutional Investors Weigh In On Perrigo
A number of hedge funds have recently made changes to their positions in PRGO. Headlands Technologies LLC grew its stake in Perrigo by 1,942.0% during the fourth quarter. Headlands Technologies LLC now owns 1,409 shares of the company’s stock worth $36,000 after buying an additional 1,340 shares during the last quarter. Versant Capital Management Inc acquired a new position in Perrigo in the fourth quarter worth $45,000. GAMMA Investing LLC grew its holdings in shares of Perrigo by 93.7% during the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company’s stock worth $49,000 after purchasing an additional 929 shares during the last quarter. Central Pacific Bank Trust Division increased its stake in shares of Perrigo by 33.3% in the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock valued at $51,000 after buying an additional 500 shares in the last quarter. Finally, Venturi Wealth Management LLC increased its stake in shares of Perrigo by 97.8% in the fourth quarter. Venturi Wealth Management LLC now owns 4,215 shares of the company’s stock valued at $108,000 after buying an additional 2,084 shares in the last quarter. Institutional investors and hedge funds own 95.91% of the company’s stock.
Perrigo Company Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Stories
- Five stocks we like better than Perrigo
- How to Plot Fibonacci Price Inflection Levels
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- The 3 Most Talked About Investments on WallStreetBets Right Now
- What is the NASDAQ Stock Exchange?
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.